Activation of deoxycytidine kinase by gamma-irradiation and inactivation by hyperosmotic shock in human lymphocytes

Biochemical Pharmacology

Volumn 65, Issue 12, 2003, Pages 2031-2039

  Csapo, Zsolt ^a   Keszler, Gergely ^a   Safrany, Geza ^b   Spasokoukotskaja, Tatjana ^a   Talianidis, Iannis ^c   Staub, Maria ^a   Sasvari Szekely, Maria ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b National Research Institute for Radiobiology and Radiohygiene Budapest   (Hungary)

^c INSTITUTE OF MOLECULAR BIOLOGY AND BIOTECHNOLOGY   (Greece)

Author keywords

Calyculin A; Deoxycytidine kinase; DNA repair; Enzyme activation; Nucleotide metabolism; Irradiation

Indexed keywords

CALYCULIN A; DEOXYCYTIDINE KINASE; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN INHIBITOR; THYMIDINE;

ARTICLE; COMET ASSAY; CONTROLLED STUDY; DATA ANALYSIS; DNA DAMAGE; DNA REPAIR; DRUG INHIBITION; ENZYME ACTIVATION; ENZYME ACTIVITY; EVIDENCE BASED MEDICINE; GAMMA IRRADIATION; GAMMA RADIATION; HUMAN; HUMAN CELL; HYPEROSMOLALITY; INCUBATION TIME; LYMPHOCYTE; OBSERVATION; OSMOTIC STRESS; PHOSPHORYLATION; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIATION DOSE;

EID: 0038730444     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(03)00182-5     Document Type: Article

References (41)

1. Arner E.S., Eriksson S. Mammalian deoxyribonucleoside kinases. Pharmacol. Ther. 67:1995;155-186.
2. Staub M., Spasokukotskaja T., Benczur M., Antoni F. DNA synthesis and nucleoside metabolism in human tonsillar lymphocyte subpopulations. Acta Otolaryngol. Suppl. 454:1988;118-124.
3. Stuart P., Ito M., Stewart C., Conrad S.E. Induction of cellular thymidine kinase occurs at the mRNA level. Mol. Cell Biol. 5:1985;1490-1497.
4. Arner E.S., Spasokoukotskaja T., Juliusson G., Liliemark J., Eriksson S. Phosphorylation of 2-chlorodeoxyadenosine (CdA) in extracts of peripheral blood mononuclear cells of leukemic patients. Br. J. Haematol. 87:1994;715-718.
5. Ruiz van Haperen V.W., Peters G.J. New targets for pyrimidine antimetabolites for the treatment of solid tumours. 2: Deoxycytidine kinase. Pharm. World Sci. 16:1994;104-112.
6. Galmarini C.M., Mackey J.R., Dumontet C. Nucleoside analogues: mechanisms of drug resistance and reversal strategies. Leukemia. 15:2001;875-890.
7. Sasvari-Szekely M., Spasokoukotskaja T., Szoke M., Csapo Z., Turi A., Szanto I., Eriksson S., Staub M. Activation of deoxycytidine kinase during inhibition of DNA synthesis by 2-chloro-2′-deoxyadenosine (Cladribine) in human lymphocytes. Biochem. Pharmacol. 56:1998;1175-1179.
8. Bergman A.M., Munch-Petersen B., Jensen P.B., Sehested M., Veerman G., Voorn D.A., Smid K., Pinedo H.M., Peters G.J. Collateral sensitivity to gemcitabine (2′,2′-difluorodeoxycytidine) and cytosine arabinoside of daunorubicin- and VM-26-resistant variants of human small cell lung cancer cell lines. Biochem. Pharmacol. 61:2001;1401-1408.
9. Spasokoukotskaja T., Sasvari-Szekely M., Keszler G., Albertioni F., Eriksson S., Staub M. Treatment of normal and malignant cells with nucleoside analogues and etoposide enhances deoxycytidine kinase activity. Eur. J. Cancer. 35:1999;1862-1867.
10. Csapo Z., Sasvari-Szekely M., Spasokoukotskaja T., Talianidis I., Eriksson S., Staub M. Activation of deoxycytidine kinase by inhibition of DNA synthesis in human lymphocytes. Biochem. Pharmacol. 61:2001;191-197.
11. Ooi K., Ohkubo T., Higashigawa M., Kawasaki H., Sakurai M. Increased deoxycytidine kinase activity by etoposide in L1210 murine leukemic cells. Biol. Pharm. Bull. 19:1996;1382-1383.
12. Sakurada K., Zheng B., Kuo J.F. Comparative effects of protein phosphatase inhibitors (okadaic acid and calyculin A) on human leukemia HL60m, HL60/ADR and K562 cells. Biochem. Biophys. Res. Commun. 187:1992;488-492.
13. Singh N.P., McCoy M.T., Tice R.R., Schneider E.L. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 175:1988;184-191.
14. Spasokukotskaja T., Spyrou G., Staub M. Deoxycytidine is salvaged not only into DNA but also into phospholipid precursors. Biochem. Biophys. Res. Commun. 155:1988;923-929.
15. Szyfter K., Sasvari-Szekely M., Spasokukotskaja T., Antoni F., Staub M. Pyrimidine salvage enzymes in human tonsil lymphocytes: II. Purification and properties of deoxycytidine kinase. Acta Biochim. Biophys. Acad. Sci. Hung. 20:1985;173-182.
16. Arner E.S., Spasokoukotskaja T., Eriksson S. Selective assays for thymidine kinase 1 and 2 and deoxycytidine kinase and their activities in extracts from human cells and tissues. Biochem. Biophys. Res. Commun. 188:1992;712-718.
17. Hatzis P., Al-Madhoon A.S., Jullig M., Petrakis T.G., Eriksson S., Talianidis I. The intracellular localization of deoxycytidine kinase. J. Biol. Chem. 273:1998;30239-30243.
18. Karlsson A., Johansson M., Eriksson S. Cloning and expression of mouse deoxycytidine kinase. Pure recombinant mouse and human enzymes show differences in substrate specificity. J. Biol. Chem. 269:1994;24374-24378.
19. Suganuma M., Fujiki H., Suguri H., Yoshizawa S., Hirota M., Nakayasu M., Ojika M., Wakamatsu K., Yamada K., Sugimura T. Okadaic acid: an additional non-phorbol-12-tetradecanoate-13-acetate-type tumor promoter. Proc. Natl. Acad. Sci. U.S.A. 85:1988;1768-1771.
20. Parrott L.A., Templeton D.J. Osmotic stress inhibits p70/85 S6 kinase through activation of a protein phosphatase. J. Biol. Chem. 274:1999;24731-24736.
21. Meier R., Thelen M., Hemmings B.A. Inactivation and dephosphorylation of protein kinase B alpha (PKB alpha) promoted by hyperosmotic stress. EMBO J. 17:1998;7294-7303.
22. Kultz D., Madhany S., Burg M.B. Hyperosmolality causes growth arrest of murine kidney cells. Induction of GADD45 and GADD153 by osmosensing via stress-activated protein kinase 2. J. Biol. Chem. 273:1998;13645-13651.
23. Spasokukotskaja T., Sasvari-Szekely M., Taljanidisz J., Staub M. Compartmentation of dCTP pools disappears after hydroxyurea or araC treatment in lymphocytes. FEBS Lett. 297:1992;151-154.
24. Xu Y.Z., Huang P., Plunkett W. Functional compartmentation of dCTP pools. Preferential utilization of salvaged deoxycytidine for DNA repair in human lymphoblasts. J. Biol. Chem. 270:1995;631-637.
25. 3H ]thymidine incorporation in stimulated lymphocytes Biochim. Biophys. Acta. 762:1983;452-457.
26. Sasvari-Szekely M., Spasokukotskaja T., Staub M. Deoxyribocytidine is salvaged not only into DNA but also into phospholipid precursors. IV. Exogenous deoxyribocytidine can be used with the same efficacy as (ribo)cytidine for lipid activation. Biochem. Biophys. Res. Commun. 194:1993;966-972.
27. Kreder N.C., van Bree C., Peters G.J., Loves W.J., Haveman J. Enhanced levels of deoxycytidine kinase and thymidine kinase 1 and 2 after pulsed low dose rate irradiation as an adaptive response to radiation. Oncol. Rep. 9:2002;141-144.
28. Boothman D.A., Davis T.W., Sahijdak W.M. Enhanced expression of thymidine kinase in human cells following ionizing radiation. Int. J. Radiat. Oncol. Biol. Phys. 30:1994;391-398.
29. Van Den Neste E., Cardoen S., Husson B., Rosier J.F., Delacauw A., Ferrant A., Van de Berghe G., Bontemps F. 2-Chloro-2′-deoxyadenosine inhibits DNA repair synthesis and potentiates UVC cytotoxicity in chronic lymphocytic leukemia B lymphocytes. Leukemia. 16:2002;36-43.
30. Wei S., Ageron-Blanc A., Petridis F., Beaumatin J., Bonnet S., Luccioni C. Radiation-induced changes in nucleotide metabolism of two colon cancer cell lines with different radiosensitivities. Int. J. Radiat. Biol. 75:1999;1005-1013.
31. Roig J., Traugh J.A. p21-activated protein kinase gamma-PAK is activated by ionizing radiation and other DNA-damaging agents. Similarities and differences to alpha-PAK. J. Biol. Chem. 274:1999;31119-31122.
32. Wang L.M., Kucera G.L. Deoxycytidine kinase is phosphorylated in vitro by protein kinase C alpha. Biochim. Biophys. Acta. 1224:1994;161-167.
33. Spasokoukotskaja T., Csapo Z., Sasvari-Szekely M., Virga S., Talianidis I., Eriksson S., Staub M. Effect of phosphorylation on deoxycytidine kinase activity. Adv. Exp. Med. Biol. 486:2000;281-285.
34. Mumby M.C., Walter G. Protein serine/threonine phosphatases: structure, regulation, and functions in cell growth. Physiol. Rev. 73:1993;673-699.
35. Woetmann A., Nielsen M., Christensen S.T., Brockdorff J., Kaltoft K., Engel A.M., Skov S., Brender C., Geisler C., Svejgaard A., Rygaard J., Leick V., Odum N. Inhibition of protein phosphatase 2A induces serine/threonine phosphorylation, subcellular redistribution, and functional inhibition of STAT3. Proc. Natl. Acad. Sci. U.S.A. 96:1999;10620-10625.
36. Janssens V., Goris J. Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem. J. 353:2001;417-439.
37. Kozma S.C., Thomas G. Regulation of cell size in growth, development and human disease: PI3K, PKB and S6K. Bioessays. 24:2002;65-71.
38. Contessa J.N., Hampton J., Lammering G., Mikkelsen R.B., Dent P., Valerie K., Schmidt-Ullrich R.K. Ionizing radiation activates Erb-B receptor dependent Akt and p70 S6 kinase signaling in carcinoma cells. Oncogene. 21:2002;4032-4041.
39. Milas L., Fujii T., Hunter N., Elshaikh M., Mason K., Plumkett W., Ang K.K., Hittelman W. Enhancement of tumor radioresponse in vivo by gemcitabine. Cancer Res. 59:1999;107-114.
40. Song Q., Lavin M.F., Calyculin A. A potent inhibitor of phosphatases-1 and -2A, prevents apoptosis. Biochem. Biophys. Res. Commun. 190:1993;47-55.
41. Ceruti S., Franceschi C., Barbieri D., Malorni W., Camurri A., Giammarioli A.M., Ambrosini A., Racagni G., Cattabeni F., Abbracchio M.P. Apoptosis induced by 2-chloro-adenosine and 2-chloro-2′-deoxy-adenosine in a human astrocytoma cell line: differential mechanisms and possible clinical relevance. J. Neurosci. Res. 60:2000;388-400.